Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Optimax Holdings BhdXKLS:0222 69 3-Year EBITDA Growth Rate is 6.90% as of Jun. 2026, which is 61% below its 10-year median of 17.90. GuruFocus rates XKLS:0222 with a GF Score™ of 69/100 and a GF Value™ of RM0.73 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 526 Healthcare Providers & Services companies, Optimax Holdings Bhd ranks worse than 56.65% on this metric.
During the past 12 months, Optimax Holdings Bhd's average EBITDA Per Share Growth Rate was -1.40% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 6.90% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 19.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Optimax Holdings Bhd was 28.40% per year. The lowest was 3.70% per year. And the median was 17.90% per year.
Optimax Holdings Bhd (XKLS:0222) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Optimax Holdings Bhd 3-Year EBITDA Growth Rate Related Terms
XKLS:0222 vs HCA, THC, EHC: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, Optimax Holdings Bhd's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optimax Holdings Bhd 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Optimax Holdings Bhd's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Optimax Holdings Bhd's 3-Year EBITDA Growth Rate falls into.
Optimax Holdings Bhd 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 6.90% mean?
Optimax Holdings Bhd (XKLS:0222) has a 3-Year EBITDA Growth Rate of 6.90% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Optimax Holdings Bhd and its competitors. This is 61% below median its historical median of 17.90. Over the past decade, Optimax Holdings Bhd's 3-Year EBITDA Growth Rate has ranged from 3.70 to 28.40. According to the industry distribution chart, Optimax Holdings Bhd ranks #298 out of 526 companies in the Healthcare Providers & Services industry, placing it in the top 56.7%.
Is Optimax Holdings Bhd's 3-Year EBITDA Growth Rate too high?
Optimax Holdings Bhd's current 3-Year EBITDA Growth Rate of 6.90% is 61% below median its 10-year median of 17.90. Over the past 10 years, this metric has ranged from a low of 3.70 to a high of 28.40. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.05. Optimax Holdings Bhd's value of 6.90% is 31.3% below this industry median. Based on the distribution chart, Optimax Holdings Bhd ranks #298 out of 526 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Optimax Holdings Bhd has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Optimax Holdings Bhd's 3-Year EBITDA Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Optimax Holdings Bhd ranks #298 out of 526 companies for 3-Year EBITDA Growth Rate. This places Optimax Holdings Bhd in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.05. Optimax Holdings Bhd's value of 6.90% is 31.3% below this benchmark. Historically, Optimax Holdings Bhd's own 3-Year EBITDA Growth Rate has ranged from 3.70 to 28.40 over the past decade. While the company's 10-year median is 17.90 vs. the industry median of 10.05, Optimax Holdings Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.05, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Optimax Holdings Bhd's current 3-Year EBITDA Growth Rate of 6.90% is 31.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Optimax Holdings Bhd and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optimax Holdings Bhd's current 3-Year EBITDA Growth Rate is 6.90%, which is 61% below median its own 10-year median of 17.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimax Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Optimax Holdings Bhd (XKLS:0222) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.73, compared to a current price of RM0.52 — trading 28.8% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 6.90%, which is 61% below median its 10-year median of 17.90 and 31.3% below the Healthcare Providers & Services industry median of 10.05. Optimax Holdings Bhd's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Optimax Holdings Bhd (XKLS:0222), the current 3-Year EBITDA Growth Rate is 6.90% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Optimax Holdings Bhd (XKLS:0222) Overvalued in 2026?
Based on GuruFocus' analysis, Optimax Holdings Bhd stock appears to be undervalued.
The current stock price of RM0.52 is trading 28.8% below its estimated GF Value™ of RM0.73.
GuruFocus considers Optimax Holdings Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0222:
3-Year EBITDA Growth Rate: 6.90% (61% below median its 10-year median of 17.90)
GF Value™: RM0.73 vs. price of RM0.52 (28.8% below fair value)
Industry Position: 31.3% below the Healthcare Providers & Services median (#298 of 526)
No single metric tells the full story. See the XKLS:0222 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Optimax Holdings Bhd is a provider of eye specialist services. The company offers a range of services with in-house medical ophthalmology at specialist centres such as specialist clinics, ambulatory care centres, satellite clinics, and specialist hospitals. The company's ambulatory care centres and specialist hospital are equipped with eye operation theatres, and procedure rooms, general and day care wards, and relevant equipment for surgical procedures. It derives revenue from refractive surgery, treatment of eye diseases and disorders, consultation and dispensary services, oculoplastic surgery, plastic Surgery and aesthetic Services and related services. The company operates in geographical segments such as: North Malaysia, Central Malaysia, South Malaysia, East Malaysia and Cambodia.
69GF Score
Get the complete analysis for XKLS:0222
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0222 has been successfully added to your 
